Ampicillin-resistant non-β-lactamase-producing Haemophilus influenzae in Spain: Recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 7, 2007, Pages 2564-2573

  García Cobos, Silvia ^a   Campos, José ^a,b   Lázaro, Edurne ^c   Román, Federico ^a   Cercenado, Emilia ^d   García Rey, César ^e   Pérez Vázquez, María ^a   Oteo, Jesús ^a   De Abajo, Francisco ^c  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b CSIC   (Spain)

^c Area de Farmacovigilancia   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e GLAXOSMITHKLINE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAMASE; CEFACLOR; CEFIXIME; CEFOTAXIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; PENICILLIN BINDING PROTEIN; PENICILLIN DERIVATIVE;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; DRUG USE; FTSI GENE; GENE SEQUENCE; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN MOTIF; PULSED FIELD GEL ELECTROPHORESIS; SPAIN;

AMINO ACID SUBSTITUTION; AMPICILLIN RESISTANCE; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEFIXIME; CEFOTAXIME; CEPHALOSPORIN RESISTANCE; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; GENES, BACTERIAL; HAEMOPHILUS INFLUENZAE; HISTIDINE; HUMANS; LYSINE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SPAIN; VARIATION (GENETICS);

EID: 34447256788     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00354-07     Document Type: Article

References (37)

1. Aracil, B., M. Slack, M. Perez-Vázquez, F. Roman, M. Ramsay, and J. Campos. 2006. Molecular epidemiology of Haemophilus influenzae type b causing vaccine failures in the United Kingdom. J. Clin. Microbiol. 44:1645-1649.
2. Bell, S. M., and D. Plowman. 1980. Mechanisms of ampicillin resistance in Haemophilus influenzae from respiratory tract. Lancet i:279-280.
3. Campos, J., M. Chanyangam, R. deGroot, A. L. Smith, F. C. Tenover, and R. Reig. 1989. Genetic relatedness of antibiotic resistance determinants in multiply resistant Haemophilus influenzae. J. Infect. Dis. 160:810-817.
4. Campos, J., S. Garcia-Tornel, and I. Sanfeliu. 1984. Susceptibility studies of multiply resistant Haemophilus influenzae isolated from pediatric patients and contacts. Antimicrob. Agents Chemother. 25:706-709.
5. Campos, J., M. Hernando, F. Roman, M. Perez-Vazquez, B. Aracil, J. Oteo, E. Lázaro, F. de Abajo, and Group of Invasive Haemophilus Infections of the Autonomous Community of Madrid, Spain. 2004. Analysis of invasive Haemophilus influenzae infections after extensive vaccination against H. influenzae type b. J. Clin. Microbiol. 42:524-529.
6. Campos, J., and J. A. Sáez-Nieto. 2001. Gram-negative infections: Haemophilus and other clinically relevant gram-negative coccobacilli, p. 557-580. In N. Cimolai (ed.), Laboratory diagnosis of bacterial infections. Marcel Dekker, Inc., New York, NY.
7. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing, fifteenth edition. Approved standard M100-S15. Clinical and Laboratory Standards Institute, Wayne, PA.
8. Dabernat, H., C. Delmas, M. Seguy, R. Pelisser, G. Faucon, S. Bennamani, and C. Pasquier. 2002. Diversity of beta-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob. Agents Chemother. 46:2208-2218.
9. Doern, G. V., A. B. Brueggemann, G. Pierce, H. P. Holley, Jr., and A. Rauch. 1997. Antibiotic resistance among clinical isolates of Haemophilus influenzae in the United States in 1994 and 1995 and detection of beta-lactamase-positive strains resistant to amoxicillin-clavulanate: results of a national multicenter surveillance study. Antimicrob. Agents Chemother. 41:292-297.
10. Falla, T. J., D. W. Crook, L. N. Brophy, D. Maskell, J. S. Kroll, and E. R. Moxon. 1994. PCR for capsular typing of Haemophilus influenzae. J. Clin. Microbiol. 32:2382-2386.
11. Fleischmann, R. D., M. D. Adams, O. White, R. A. Clayton, E. F. Kirkness, A. R. Kerlavage, C. J. Bult, J. F. Tomb, B. A. Dougherty, J. M. Merrick, K. McKenney, G. Sutton, W. FitzHugh, C. Fields, J. D. Gocayne, J. Scott, R. Shirley, L. Liu, A. Glodek, J. M. Kelley, J. F. Weidman, C. A. Phillips, T. Spriggs, E. Hedblom, M. D. Cotton, T. R. Utterback, M. C. Hanna, D. T. Nguyen, D. M. Saudek, R. C. Brandon, L. D. Fine, J. L. Fritchman, J. L. Fuhrmann, N. S. M. Geoghagen, C. L. Gnehm, L. A. McDonald, K. V. Small, C. M. Fraser, H. O. Smith, and J. C. Venter. 1995. Whole-genome random sequencing and assembly of Haemophilus influenzae Rd. Science 269:496-512.
12. Fluit, A. C., A. Florijn, J. Verhoef, and D. Milatovic. 2005. Susceptibility of European beta-lactamase-positive and -negative Haemophilus influenzae isolates from the periods 1997/1998 and 2002/2003. J. Antimicrob. Chemother. 56:133-138.
13. García-Rodríguez, J. A., F. Baquero, J. García de Lomas, L. Aguilar, and the Spanish Surveillance Group for Respiratory Pathogens. 1999. Antimicrobial susceptibility of 1,422 Haemophilus influenzae isolates from respiratory tract infections in Spain: results of 1-year (1996-97) multicenter surveillance study. Infection 27:265-267.
14. Gazagne, L., C. Delmas, E. Bingen, and H. Dabernat. 1998. Molecular epidemiology of ampicillin-resistant non-beta-lactamase-producing H. influenzae. J. Clin. Microbiol. 36:3629-3635.
15. Goossens, H., M. Ferech, R. Vander Stichele, M. Elseviers, and ESAC Project Group. 2005. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365:579-587.
16. Hasegawa, K., N. Chiba, R. Kobayashi, S. Y. Murayama, S. Iwata, K. Sunakawa, and K. Ubukata. 2004. Rapidly increasing prevalence of beta-lactamase-nonproducing, ampicillin-resistant Haemophilus influenzae type b in patients with meningitis. Antimicrob. Agents Chemother. 48:1509-1514.
17. Hasegawa, K., R. Kobayashi, E. Takada, A. Ono, N. Chiba, M. Morozumi, S. Iwata, K. Sunakawa, K. Ubukata, and Working Group of the Nationwide Surveillance for Bacterial Meningitis. 2006. High prevalence of type b beta-lactamase-non-producing ampicillin-resistant Haemophilus influenzae in meningitis: the situation in Japan where Hib vaccine has not been introduced. J. Antimicrob. Chemother. 57:1077-1082.
18. Hasegawa, K., K. Yamamoto, N. Chiba, R. Kobayashi, K. Nagai, M. R. Jacobs, P. C. Appelbaum, K. Sunakawa, and K. Ubukata. 2003. Diversity of ampicillin-resistance genes in Haemophilus influenzae in Japan and the United States. Microb. Drug Resist. 9:39-46.
19. Jansen, W. T., A. Verel, M. Beitsma, J. Verhoef, and D. Milatovic. 2006. Longitudinal European surveillance study of antibiotic resistance of Haemophilus influenzae. J. Antimicrob. Chemother. 58:873-877.
20. Kaczmarek, F. S., T. D. Gootz, F. Dib-Hajj, W. Shang, S. Hallowell, and M. Cronan. 2004. Genetic and molecular characterization of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae with unusually high resistance to ampicillin. Antimicrob. Agents Chemother. 48:1630-1639.
21. Karlowsky, J. A., I. A. Critchley, R. S. Blosser-Middleton, E. A. Karginova, M. E. Jones, C. Thornsberry, and D. F. Sahm. 2002. Antimicrobial surveillance of Haemophilus influenzae in the United States during 2000-2001 leads to detection of clonal dissemination of a beta-lactamase- negative and ampicillin-resistant strain. J. Clin. Microbiol. 40:1063-1066.
22. Kim, I. S., C. S. Ki, S. Kim, W. S. Oh, K. R. Peck, J. H Song, K. Lee, and N. Y. Lee. 2007. Diversity of ampicillin resistance genes and antimicrobial susceptibility patterns in Haemophilus influenzae isolated in Korea. Antimicrob. Agents Chemother. 51:453-460.
23. Marco, F., J. Garcia-de-Lomas, C. Garcia-Rey, E. Bouza, L. Aguilar, and C. Fernandez-Mazarrasa. 2001. Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999. Antimicrob. Agents Chemother. 45:3226-3228.
24. Markowitz, S. M. 1980. Isolation of an ampicillin-resistant, non-beta-lactamase-producing strain of Haemophilus influenzae. Antimicrob. Agents Chemother. 17:80-83.
25. Matic, V., B. Bozdogan, M. R. Jacobs, K. Ubukata, and P. C. Appelbaum. 2003. Contribution of beta-lactamase and PBP amino acid substitutions to amoxicillin/clavulanate resistance in beta-lactamases-positive, amoxicillin/clavulanate-resistant Haemophilus influenzae. J. Antimicrob. Chemother. 52:1018-1021.
26. Mendelman, P. M. 1992. Targets of the beta-lactam antibiotics, penicillin-binding proteins, in ampicillin-resistant, non-beta-lactamase- producing Haemophilus influenzae. J. Infect. Dis. 165(Suppl. 1):107-109.
27. Mendelman, P. M., D. O. Chaffin, J. M. Musser, R. DeGroot, D. A. Serfass, and R. K. Selander. 1987. Genetic and phenotypic diversity among ampicillin-resistant, non-beta-lactamase-producing, nontypeable Haemophilus influenzae isolates. Infect. Immun. 55:2585-2589.
28. Mendelman, P. M., D. O. Chaffin, T. L. Stull, C. E. Rubens, K. D. Mack, and A. L. Smith. 1984. Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob. Agents Chemother. 26:235-244.
29. O'Callaghan, C. H., A. Morris, S. M. Kirby, and A. H. Shinger. 1972. Novel method for detection of beta-lactamase by using a chromogenic cephalosporin substrate. Antimicrob. Agents Chemother. 1:283-288.
30. Parr, T. R., Jr., and L. E. Bryan. 1984. Mechanism of resistance of an ampicillin-resistant, beta-lactamase-negative clinical isolate of Haemophilus influenzae type b to beta-lactam antibiotics. Antimicrob. Agents Chemother. 25:747-753.
31. Pérez-Trallero, E., C. García de la Fuente, C. García-Rey, F. Baquero, L. Aguilar, R. Dal-Ré, J. García-de-Lomas, and the Spanish Surveillance Group for Respiratory Pathogens. 2005. Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain. Antimicrob. Agents Chemother. 49:1965-1972.
32. Sanbongi, Y., T. Suzuki, Y. Osaki, N. Senju, T. Ida, and K. Ubukata. 2006. Molecular evolution of beta-lactam-resistant Haemophilus influenzae: 9-year surveillance of penicillin-binding protein 3 mutations in isolates from Japan. Antimicrob. Agents Chemother. 50:2487-2492.
33. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
34. Turnidge, J., and K. Christiansen. 2005. Antibiotic use and resistance - proving the obvious. Lancet 365:548-549.
35. Ubukata, K. 2003. Problems associated with high prevalence of multidrug-resistant bacteria in patients with community-acquired infections. J. Infect. Chemother. 9:285-291.
36. Ubukata, K., Y. Shibasaki, K. Yamamoto, N. Chiba, K. Hasegawa, Y. Takeuchi, K. Sunakawa, M. Inoue, and M. Konno. 2001. Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob. Agents Chemother. 45:1693-1699.
37. WHO Collaborating Centre for Drug Statistics Methodology. 2005. Guidelines for ATC classification and DDD assignment. WHO, Oslo, Norway.